BGI’s Rapid Antigen Test is available now
BGI announces that its 2019-nCoV Ag Test has recently been included in the Australian Register of Therapeutic Goods (ARTG).
The test kit is designed for detecting SARS CoV-2 nucleocapsid protein antigen for individuals suspected to have contracted COVID-19.
BGI Spatial Omics Workshop at Lorne Genome
BGI Australia and Decode Science hosted a Spatial Genomics workshop featuring the BGI STomics technology during the Lorne Genome Conference. BGI's latest innovation in spatial omics BGI STOmics, a proprietary advanced spatially-resolved transcriptomic analysis technology, brings researchers a revolutionary tool to explore spatial biology with unprecedented field-of-view and resolution. The workshop showcases the discoveries that early access customers in Australia have made using this technology with invited speakers Dr. Dane Vassiliadis from Peter MacCallum Cancer Centre, and Dr. Ankur Sharma from Harry Perkins Institute sharing their exciting research using the new technology. View the recording at the link.
Announcing BGI Genomics ANZ Grant Winners
We are pleased to announce the winners of the 2021 BGI Genomics ANZ Grant. Congratulations to the winners!
- 1st Winner- Dr. Imran Khan, Peter MacCallum Cancer Centre
- 2nd Winner- Dr. Dmitrii Shek, Western Sydney University
Applications closed! We thank all the applicants for their efforts in submitting the applications. Subscribe to our mailing list for future grant opportunities. Contact us at BGI-Australia@genomics.cn for general inquiries.
2021 MGI DNBSEQ™ MPS Research Grant Winners
Drumroll... MGI announces 2021 DNBSEQ™ MPS Research Grant winners: Dr. Christian Nefzger, University of Queensland, Dr. Darren Korbie, University of Queensland, A. Prof. Michael Hildebrand, University of Melbourne, Dr. Hii Kieng Soon, University of Malaya, and Dr. Colm Carraher, Plant&Food Research. Congratulations!
BGI AU Contributes to Safeguarding Queensland from COVID-19
BGI Australia is proud to be the supplier for Pathology Queensland’s testing equipment and kits, contributing to safeguarding the people living in Queensland. BGI’s proprietary COVID-19 Testing Solution installed in the Pathology Queensland Infectious Diseases Lab (IDL) in Herston Health Precinct has officially started operation in April by running samples that are collected from across the river city. The “BGI system”, dubbed by the lab staff, surpassed the 10,000-test milestone in less than a month. The integrated system is expected to handle 4,700 tests daily at the maximum capacity, with a 24-hour turnaround time from swab collection at a clinic or hospital, to reported result.
Dr. Ian Mackay, the IDL’s Senior Molecular Scientist said, “our approach is to establish a diverse portfolio of advanced technologies to best serve Queenslanders. We appreciate how quickly the BGI team respond to our ongoing technical needs and how efficiently the equipment and testing kits were supplied. We are handling approximately 1,100 tests per day as there is no community transmission in the Brisbane region, but the number we process continues to grow and we are well placed to respond should any new clusters occur in Brisbane’s future.”
With a local team of technical specialists and engineers, BGI Australia offers strong support to the customers across Australia. Dr. Bicheng Yang, Director of BGI Australia, said “This project is very special for us as Brisbane is our home city, where most of the team members are based, and we are located in the same building as IDL. This certainly will benefit response time and service to ensure that everything runs smoothly and sustains the highest quality to deliver reliable results for the tests.”
The Pathology Queensland Infectious Diseases Laboratory is a high-throughput molecular laboratory operating in Herston, with surge capacity to assist other Pathology Queensland laboratories across Queensland. Pathology Queensland, part of Queensland Health, provides diagnostic pathology services to all Hospital and Health Services across metro, regional and remote Queensland.
Please read the full media release below.
What's New
COVID-19 Updates
Promotions & Grants
COVID-19 Updates
BGI’s remarkable journey fighting COVID-19, from BGI’s emergency response since the very beginning of the outbreak to BGI’s battle-proven COVID-19 solutions to provide timely detection and intervention support.
News
Promotions & Grants
COVID-19 Updates
Check in on the latest news at BGI Australia.
- BGI partners with Minderoo to launch Huo-Yan Laboratory Solution to expedite Australia-wide COVID-19 testing.
Promotions & Grants
Promotions & Grants
Promotions & Grants
Keep an eye out here for our promotions and grants. Be notified when applications open.
Explore
Core Capability
Core Capability
Core Capability
Since the completion of Human Genome Project, BGI has evolved into a genomics giant with a global footprint. Its core capabilities cover research, sequencing services, advanced tools for life sciences, and reading, writing, and storage of genetic resources,
Research
Core Capability
Core Capability
BGI is committed to multi-disciplinary research in life sciences, biotechnology and healthcare applications. Today, BGI actively participates in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a network of collaborators.
Instruments
Core Capability
Instruments
Check out our latest range of MGI sequencing platforms and diagnostic devices.
Services
Customer Testimonials
Instruments
We provide a wide array of integrated genomic sequencing services and proteomic services across a broad range of applications in basic research, clinical research, genetic testing and screening, drug discovery and development, agriculture and biodiversity preservation and sustainability.
Partners
Customer Testimonials
Customer Testimonials
We believe that partnerships are critical to help foster innovation and growth. We partner with diverse players from research and industry organizations who share our vision. We have formed strong alliances within the genomics community and beyond, and continuously seek collaborative opportunities.
Customer Testimonials
Customer Testimonials
Customer Testimonials
We are committed to our customers’ success, and aim for excellence as we work together to find new ways to engage, support customers and identify exciting development opportunities.
